CONSULTANT HEPTOLOGIST & GASTROENTEROLOGIST
HEPTOLOGIST & GASTROENTEROLOGIST
Qualifications: MB BCH BAO BMEDSCI FRCP MD
Language: English, French
Expertise: Reader in Hepatology, Consultant Gastroenterologist and Hepatologist. Fibroscan; alcohol, fatty and viral liver disease. Abdominal & gallstone pain. Endoscopy & ERCP.
Professor Patrick Kennedy is a Consultant Hepatologist and Gastroenterologist at Barts Health NHS Trust. He graduated from University College Dublin and completed his post-graduate medical training in Gastroenterology and Hepatology in London. He was appointed as a Clinical Senior Lecturer in Hepatology at Barts and The London School of Medicine & Dentistry in 2009.
Professor Kennedy’s work in viral liver disease is known internationally and he is widely published in the field. He has produced novel work redefining disease phase in hepatitis B virus (HBV) and investigating the role of individualised treatment & management strategies for chronic hepatitis B (CHB) patients.
Professor Patrick Kennedy’s main clinical interests include viral liver disease; focusing on disease assessment and stratification using novel virological and immunological approaches. Translating these novel tools to clinical practice and evaluating their utility against conventional non-invasive modalities such as Fibroscan is a key element of his work. As an experienced Hepatologist Professor Kennedy manages all aspects of liver disease including alcohol, fatty liver disease and liver failure. He has a specialist interest in liver disease affecting young people and runs a dedicated young adult liver service at The Royal London Hospital. He also manages liver disease for professional sports people and elite athletes across the United Kingdom and abroad.
Professor Kennedy leads the British Association for the Study of the Liver (BASL) special interest group in HBV. He is a member of the viral hepatitis clinical guideline committee for NICE and provides expert opinion for the United Kingdom Advisory Panel on blood-borne viruses. He is the Hepatology lead for the Gastroenterology and Hepatology Section at the Royal Society of Medicine. In addition, he is a key opinion leader in viral liver disease and a member of expert advisory panels for Gilead, Roche and BMS. He is regularly invited to chair and speak at national and international meetings. In keeping with Professor Kennedy’s longstanding research interest and publication record in viral liver disease, he is now the chief/principal investigator for a number of investigator-led and commercial phase 1, 2 and 3, clinical trials in HBV therapy.